लोड हो रहा है...
Statin tolerability: In defence of placebo-controlled trials
BACKGROUND: Statin intolerance is a barrier to effective lipid-lowering treatment. A significant number of patients stop prescribed statins, or can take only a reduced dose, because of adverse events attributed to the statin, and are then considered statin-intolerant. METHODS: Examination of differe...
में बचाया:
| में प्रकाशित: | Eur J Prev Cardiol |
|---|---|
| मुख्य लेखकों: | , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
SAGE Publications
2015
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4847124/ https://ncbi.nlm.nih.gov/pubmed/26318980 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2047487315602861 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|